Christopher Yea - 21 Feb 2026 Form 4 Insider Report for KalVista Pharmaceuticals, Inc. (KALV)

Reporting relationship: CHIEF DEVELOPMENT OFFICER
Issuer ticker: KALV
Reported as of: 21 Feb 2026
Net transaction value: -$67,669
SEC form: 4
Accepted by SEC: 24 Feb 2026, 19:43:20 UTC
Prior SEC filing: 19 Feb 2026
Next SEC filing: 19 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Benjamin L. Palleiko, Attorney-in-Fact

Key filing fact

Christopher Yea filed Form 4 for KalVista Pharmaceuticals, Inc. (KALV) on 24 Feb 2026.

Key facts

This page summarizes Christopher Yea's Form 4 filing for KalVista Pharmaceuticals, Inc. (KALV).
5 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 24 Feb 2026, 19:43.

Change

Previous filing in this sequence was filed on 19 Feb 2026.
Current net transaction value: -$67,669.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001691102 Primary reporting owner

Yea Christopher

Relationship: CHIEF DEVELOPMENT OFFICER
Address: C/O KALVISTA PHARMACEUTICALS, INC, 200 CROSSING BOULEVARD, FRAMINGHAM
Signature: /s/ Benjamin L. Palleiko, Attorney-in-Fact
Signature date: 24 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KALV transaction

Common Stock

Options Exercise

Transaction value
Shares: +3,750
Change %: +1.7%
Price
Shares after: 227,923
Date: 21 Feb 2026
Ownership: Direct
Footnotes: F1

KALV transaction

Common Stock

Options Exercise

Transaction value
Shares: +3,125
Change %: +1.4%
Price
Shares after: 231,048
Date: 22 Feb 2026
Ownership: Direct
Footnotes: F1

KALV transaction

Common Stock

Sale

Transaction value: $67,669
Shares: -4,347
Change %: -1.9%
Price: $15.57
Shares after: 226,701
Date: 23 Feb 2026
Ownership: Direct
Footnotes: F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KALV transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value: $0
Shares: -3,750
Change %: -7.7%
Price: $0.000000
Shares after: 45,000
Date: 21 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,750
Exercise price
Footnotes: F1, F4

KALV transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value: $0
Shares: -3,125
Change %: -10%
Price: $0.000000
Shares after: 28,125
Date: 22 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,125
Exercise price
Footnotes: F1, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Footnote F2

The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Footnote F3

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.5182 to $15.566982 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F4

1/16th of the total number of shares subject to the RSU shall vest on each quarterly anniversary of the Vesting Commencement Date, subject to continued service through each vesting date.